Skip to main content
Clinical Trials/NCT04081545
NCT04081545
Completed
Phase 3

The Effect of an Opioid-free Anesthetic on Post-operative Opioid Consumption After Laparoscopic Bariatric Surgery: a Prospective, Single-blinded, Randomized Controlled Trial

Christine Oryhan1 site in 1 country181 target enrollmentDecember 24, 2019

Overview

Phase
Phase 3
Intervention
Opioid Anesthetics
Conditions
Anesthesia
Sponsor
Christine Oryhan
Enrollment
181
Locations
1
Primary Endpoint
24 Hour Opioid Consumption
Status
Completed
Last Updated
last year

Overview

Brief Summary

A comparison of post-operative opioid use in laparoscopic bariatric surgery patients receiving opioid or opioid-free anesthesia.

Detailed Description

This is a prospective, single-center, single-blinded, randomized controlled trial comparing the effect of an opioid-free general anesthetic versus a traditional anesthetic with a restricted quantity of opioid on postoperative opioid consumption following laparoscopic bariatric surgery. The study population will be composed of 196 subjects undergoing laparoscopic bariatric surgery at Virginia Mason Medical center randomized into two groups. The control group will receive a traditional opioid restrictive general anesthetic. The study group will receive an opioid-free anesthetic technique.

Registry
clinicaltrials.gov
Start Date
December 24, 2019
End Date
June 30, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Christine Oryhan
Responsible Party
Sponsor Investigator
Principal Investigator

Christine Oryhan

Anesthesiologist and Pain Medicine Physician

Benaroya Research Institute

Eligibility Criteria

Inclusion Criteria

  • Adult patients undergoing elective laparoscopic bariatric surgery (i.e. laparoscopic roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy) able to provide informed consent

Exclusion Criteria

  • Any opioid use within 4 weeks prior to surgery
  • Chronic antiemetic use
  • Conversion of laparoscopic to open surgery
  • Patients unable to provide post-operative pain scores
  • Pregnant or lactating patients
  • Patients under 18 years of age
  • Refusal or inability to provide informed consent

Arms & Interventions

Control Goup A- Opioid-based regimen

Preop - Multimodals unless contraindicated Induction * Fentanyl (50mcg IV) * Lidocaine 1.5mg/kg IV bolus using IBW (Ideal body weight) * Propofol 2-3mg/kg IV bolus * Neuromuscular blockade per Anesthesiology team discretion Maintenance * Sevoflurane * Neuromuscular blockade at discretion of anesthesiology team * May use fentanyl to treat SBP or HR \> 20% of baseline Emergence * Neuromuscular reversal, dosed according to Virginia Mason protocol * May titrate fentanyl per anesthesiology team throughout the case. * Patient extubated and brought to PACU PACU opioid orders per anesthesiology team Post-operative Nausea/Vomiting Prophylaxis -4mg dexamethasone, 1mg haloperidol, scopolamine patch

Intervention: Opioid Anesthetics

Experimental Group B- Opioid-free regimen

Preop - Multimodals unless contraindicated Induction * Dexmedetomidine 1mcg/kg IV bolus over 10 minutes using IBW * Lidocaine 1.5mg/kg IV bolus using IBW * Propofol 2-3mg/kg IV bolus * Neuromuscular blockade per Anesthesiology team discretion * Ketamine 0.5mg/kg IV bolus (based on IBW) Maintenance * Sevoflurane * Dexmedetomidine 0.4 mcg/kg/hr IV infusion using IBW (may titrate based on patient response between 0.3-0.5mcg/kg/hr) * Lidocaine 2mg/kg/hr IV infusion using IBW * May use esmolol as needed to treat SBP or HR \> 20% of baseline * Neuromuscular blockade at the discretion of anesthesiology team Emergence * Dexmedetomidine infusion turned off during laparoscopic desufflation * Lidocaine infusion turned off at skin closure * Neuromuscular reversal, dosed according to VM protocol * Pt extubated and brought to PACU * PACU opioid orders per anesthesiology team Post-operative Nausea/Vomiting Prophylaxis -4mg dexamethasone, 1mg haloperidol, scopolamine patch

Intervention: Non Opioid Analgesics

Outcomes

Primary Outcomes

24 Hour Opioid Consumption

Time Frame: 24 hours

Total amount of opioid use within the first 24 hours after surgery in mg of oral morphine equivalent doses

Secondary Outcomes

  • Length of Time Under General Anesthesia(1-5 hours)
  • Percentage of Patients With Opioid-related Adverse Effects(24 hours)
  • Length of Time to Recover From General Anesthesia(1-3 hours)
  • Length of Hospital Stay(1-5 days)
  • Overall Patient Satisfaction With Analgesia: Yes or no(24 hours)
  • Number of Participants With Post-surgical Opioid Prescription Refills up to 30 Days(30 days)
  • Percentage of Patients Treated for General Anesthetic Adverse Effects(Intraoperative, between time entering OR and PACU arrival time)
  • Number of Participants With Post-surgical Opioid Prescription Refills Between 30 Days to 3 Months After Surgery(3 months)

Study Sites (1)

Loading locations...

Similar Trials